Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Glenmark Pharmaceuticals Limited
Press Release Nov 07 2023
Business
Nov 7 2023
3 min read

Press Release Nov 07 2023

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 07, 2023, titled "Glenmark Pharmaceuticals receives ANDA approval forFluphenazine Hydrochloride Tablets USP, 1 mg, 2.5 mg, 5 mg, and 10mg".

View Attachment